TrialAntimicrobial agents and chemotherapy2022

Phase 2 Open-Label Study of Long-Term Safety, Tolerability, and Antiviral Activity of Rilpivirine in Antiretroviral-Naive Adolescents Living with HIV-1.

Johan Lombaard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.